Is URGN stock safe? | Glauxie AI

Q: Is URGN stock safe?

UroGen Pharma Ltd. (URGN) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Elizabeth A. Barrett. UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible... Employees: 200,000.

Q: What are the risks of investing in URGN?

Identify key risks of investing in URGN — debt, competition, volatility, and sector headwinds.

Q: Is URGN a good long-term investment?

Evaluate URGN as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does URGN have?

Review URGN total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is URGN stock safe?

🦉

UroGen Pharma Ltd. (URGN)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOElizabeth A. Barrett

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and...

Key Executives

Name	Title
Alison Hardgrove	Senior Vice President of Human Resources
Bryon Wornson	Executive Vice President of Talent, Advocacy & Communications
Christopher Degnan	Chief Financial Officer
David Lin	Chief Commercial Officer
Elizabeth A. Barrett	President, Chief Executive Officer & Director
James Ottinger	Executive Vice President of Regulatory Affairs & Quality

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

URGN Profile Financials

What are the risks of investing in URGN? Is URGN a good long-term investment? How much debt does URGN have?